Biotech · Private company · Cambridge, MA, US
Leuko Labs, Inc.
Track this companyFree. Adds Leuko Labs, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- PointCheckDiffuse Large B Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- PointCheckHematologic MalignancyClinicalTrials.gov · fetched Nov 12, 2026
- PointCheckNeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe NeutropeniaRECRUITING · started Dec 15, 2025ClinicalTrials.gov NCT06323447 · fetched Nov 12, 2026
- Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric PopulationCOMPLETED · started Sep 7, 2021ClinicalTrials.gov NCT04889937 · fetched Nov 12, 2026
- PC001- A Study to Evaluate the Usability of PointCheckNA · COMPLETED · started Feb 9, 2021ClinicalTrials.gov NCT04448301 · fetched Nov 12, 2026
NIH awards3
- Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with PointCheck: a portable non-invasive neutropenia analyzerFiscal year 2026 · $991.9KNIH RePORTER 5R44CA228920-06 · fetched Nov 12, 2026
- Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with PointCheck: a portable non-invasive neutropenia analyzerFiscal year 2025 · $1.8MNIH RePORTER 5R44CA228920-05 · fetched Nov 12, 2026
- Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with PointCheck: a portable non-invasive neutropenia analyzerFiscal year 2024 · $1.7MNIH RePORTER 2R44CA228920-04 · fetched Nov 12, 2026